INTERFERON-a AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 1

Michael E. De Vera; Gregory A. Smallwood; Kathia Rosado; Laurel Davis; Enrique Martinez; Shobha Sharma; Andrei C. Stieber; Thomas G. Heffron

INTERFERON-a AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 1

Michael E. De Vera, Gregory A. Smallwood, Kathia Rosado, Laurel Davis, Enrique Martinez, Shobha Sharma, Andrei C. Stieber, Thomas G. Heffron

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Transplantation
Volume	71
State	Published - Mar 15 2001

Disciplines

Gastroenterology
Internal Medicine
Medicine and Health Sciences

OpenUrl availability

Full text

Cite this

@article{f8743bd3ed394d5787fc4e8600314d2e,

title = "INTERFERON-a AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 1",

author = "\{De Vera\}, \{Michael E.\} and Smallwood, \{Gregory A.\} and Kathia Rosado and Laurel Davis and Enrique Martinez and Shobha Sharma and Stieber, \{Andrei C.\} and Heffron, \{Thomas G.\}",

note = "ith recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-α (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o. daily) for 12 months or more. Serum aminotransferases, HCV RNA, and severity of hepatitis were followed.",

year = "2001",

month = mar,

day = "15",

language = "American English",

volume = "71",

journal = "Transplantation",

}

TY - JOUR

T1 - INTERFERON-a AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 1

AU - De Vera, Michael E.

AU - Smallwood, Gregory A.

AU - Rosado, Kathia

AU - Davis, Laurel

AU - Martinez, Enrique

AU - Sharma, Shobha

AU - Stieber, Andrei C.

AU - Heffron, Thomas G.

N1 - ith recurrent HCV (elevated serum aminotransferases, positive serum HCV RNA, and biopsy-proven hepatitis without rejection) received interferon-α (1.5-3 million units subcutaneously three times a week) and ribavirin (400-1000 mg p.o. daily) for 12 months or more. Serum aminotransferases, HCV RNA, and severity of hepatitis were followed.

PY - 2001/3/15

Y1 - 2001/3/15

UR - https://journals.lww.com/transplantjournal/Fulltext/2001/03150/INTERFERON___AND_RIBAVIRIN_FOR_THE_TREATMENT_OF.19.aspx

M3 - Article

VL - 71

JO - Transplantation

JF - Transplantation

ER -

INTERFERON-a AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 1

Disciplines

OpenUrl availability

Other files and links

Cite this